Reduction of Cold-Induced Hypertension by Antisense
Oligodeoxynucleotides to Angiotensinogen mRNA and AT 1 -Receptor mRNA in Brain and Blood R ats exposed to mild cold (5°C/41°F) develop hypertension. [1] [2] [3] [4] This CIH is a nongenetic, nonsurgical model for studying hypertension in rats. Our previous studies have shown that the blood-borne RAS either prevents or attenuates CIH. 5, 6 The mechanism also appears to involve both peripheral tissue and central RAS because there is increased mRNA for AGT and/or AT 1 -R in brain and peripheral tissues, 7 increased spontaneous drinking response, and increased dipsogenic response to acute administration of Ang II either centrally or subcutaneously. 8 The receptors for Ang II in the diencephalon of rats have been correlated directly with the drinking response to Ang II. 9, 10 Furthermore, studies also suggest that there is a direct correlation between the state of receptors for Ang II in the diencephalon and development of hypertension, ie, upregulation of receptors for Ang II has been linked to the induction of both deoxycorticosterone acetate-salt and spontaneously induced hypertension. 9 -13 Tests of the dipsogenic responsiveness to Ang II, spontaneous drinking response to cold, and AT 1 -R mRNA in brain show much greater responses in cold-treated rats. 8 This suggests that the receptors for Ang II are upregulated in rats exposed chronically to cold. Additional studies have shown an increased amount of mRNA for AGT, the substrate for the RAS, in the brains of cold-treated rats compared with rats kept at room temperature as controls. This raises the possibility that both increased production of Ang II and upregulation of Ang II receptors contribute to the elevation of BP during exposure to cold. An increased amount of mRNA of AGT and/or AT 1 -R in peripheral tissues (liver, adrenal glands, and aorta) of cold-treated rats suggests that an overactive peripheral tissue RAS is involved in CIH as well. AS-ODN, targeted to AGT mRNA or AT 1 -R mRNA, have been shown to reduce BP in SHR, which demonstrates that AS-ODN are specific and reduce an overactive RAS. 14 -18 Therefore, to assess more directly the role of the central RAS in CIH, AS-ODN to AGT mRNA and to AT 1 -R mRNA were administrated centrally, and their effects on BP and spontaneous drinking in chronically cold-exposed rats were determined. To assess the role of the peripheral RAS in CIH, AS-ODN to AT 1 -R mRNA was administered by intracardiac injection, and its effect on BP and AT 1 -R in chronically cold-exposed rats was determined. We hypothesized that central injection of AS-ODN to AGT or AT 1 -R mRNA would decrease BP and spontaneous drinking response, and that a peripheral injection of AS-ODN to AT 1 -R mRNA would decrease BP and AT 1 -R binding in cold-treated rats.
Methods

Animal Model
Forty-two adult male Sprague-Dawley rats (225 to 250 g) were acquired from Harlan. The rats were kept in individual cages in a room with a 12-hour light/dark cycle. They were given tap water to drink and standard rat chow to eat ad libitum. For a 2-week control period, the rats were kept at room temperature (25°C). During this time, SBP and body weight of each rat were measured weekly. SBP was recorded by tail cuff. After 2 weeks, all rats were transferred to ventilated chambers kept at 5Ϯ1°C. SBP and body weight were measured twice weekly by tail cuff until a significant and stable increase in SBP was noted compared with SBP before cold exposure. At the end of 5 weeks, the rats were divided randomly into seven groups (nϭ6 per group). Two groups received either AS-ODN or SCR-ODN to AGT mRNA. Two groups received either AS-ODN or SCR-ODN to AT 1 -R mRNA. One control group received ICV injection of 2 L artificial CSF. The last two groups received either AS-ODN or SCR-ODN to AT 1 -R mRNA by intracardiac injection. Before injection, the ODN were dissolved in 2 L artificial CSF at a concentration of 25 g/L. This dose has been used previously without side effects or toxicity.
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Surgical Procedures
Each rat was anesthetized with sodium pentobarbital (65 mg/kg body wt IP). Rats were mounted in a Kopf stereotaxic apparatus, and the skull was exposed. A burr hole was made, and an injector connected to a 10-L Hamilton microsyringe was lowered into place. For ICV injection, a single injection of ODN was administered into the right lateral cerebral ventricle (coordinates: 1.0 mm lateral, 1.0 mm caudal to the bregma, 5.0 mm below the skull surface). Each rat was injected with either 50 g AS-ODN or 50 g SCR-ODN (dissolved in 2 L artificial CSF) or with 2 L artificial CSF alone. SBP was recorded 24 hours later and daily until pressure had returned to the preinjection level.
Drinking Responses
Water intakes were measured gravimetrically at 24 hours for 3 days before injection and for 2 or 7 days after rats received the ICV injection of AGT-ODN or AT 1 -R-ODN mRNA.
Intracardiac Administration
For intracardiac injection, each rat was anesthetized with Metafane. Rats were injected with 100 g of either AS-ODN or SCR-ODN to AT 1 -R mRNA (in 100 L artificial CSF) directly into the heart with a 0.4ϫ12-mm needle (Monoject 250). Twenty-four hours later, SBP was recorded, the rats were then killed, and tissues were removed for autoradiography.
Oligodeoxynucleotides
The ODN was synthesized as a phosphorothioated 15-mer or 18-mer ODN at the DNA Core, University of Florida, using designs based on cDNA of AGT 19 and AT 1 -R. 20 The antisense sequence to AGT mRNA was 5Ј-CGGTGGGAGGTCACGG-3Ј, the 18-mer targeted to bases Ϫ5 to ϩ13 of AGT mRNA encompassing the AUG codon; and the AT 1 -R mRNA was 5Ј-TAACTGTGGCTGCAA-3Ј, 15-mer complementary to bases ϩ63 to ϩ77 of the AT 1 -R mRNA. Control injections contained SCR-ODN (the sequence for AGT is 5Ј-CAG GGA TCT CTG GCC GAC-3Ј and for AT 1 -R mRNA it is 5Ј-CTT ACT AGC CTA GGC-3Ј) or artificial CSF.
Autoradiography
Rats were deeply anesthetized with sodium pentobarbital (65 mg/kg body wt IP) and perfused transcardially with 0.9% saline. The tissues were removed and kept frozen at Ϫ20°C until cryostat sectioning into 20-m sections. The sections were mounted onto gelatin-coated slides. The slides were preincubated in assay buffer (150 mmol/L NaCl, 50 mmol/L sodium phosphate, 1 mmol/L EDTA, 0.1 mmol/L bacitracin, pH 7.2) for 30 minutes and then incubated with the same buffer with the addition of 500 pmol/L 125 I-Sar 1 ,Ile 8 -Ang II for 2 hours. The sections were incubated with the radioligand in the presence or absence of 1 mol/L Ang II to determine nonspecific and total receptor binding. AT 1 -R or AT 2 -R binding was determined in the presence of 1 mol/L of either PD123319 or losartan. The sections were washed and dried. Autoradiograms were generated by exposing the slides to x-ray films for 1 to 4 weeks. They were analyzed by autoradiographic densitometry (Image Systems Inc). The photos were taken directly from the image analysis system. Optical densities of the autoradiograms were determined by computerized microdensitometry, and the results are expressed in femtomoles per gram of protein after comparison with the 125 I-standard.
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Statistical Analysis
The data for SBP were analyzed by repeated measures one-way ANOVA using the Newman-Keuls procedure to assess the significance of differences between two means. For ICV injection, the data for SBP and water intakes were analyzed by a repeated measures two-way ANOVA using the Newman-Keuls procedure to assess the significance of differences between two means. For intracardiac injection, SBP and AT 1 -R and AT 2 -R binding were compared by Student's t test. A value of PϽ0.05 was considered significant.
Results
Cold-Induced Hypertension
SBP increased during 5 weeks of exposure to cold (Figure 1 ). At 1, 2, 3, 4, and 5 weeks of cold exposure, SBP was 121Ϯ1, 146Ϯ3, 149Ϯ3, 157Ϯ3, and 165Ϯ3 mm Hg, respectively. By the second week of cold exposure, SBP was significantly greater than that before cold exposure (PϽ0.01). The difference was pronounced during the fifth week of cold exposure. This result is consistent with previous studies from this laboratory in which rats exposed to chronic cold developed hypertension.
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Selected Abbreviations and Acronyms
AGT ϭ angiotensinogen Ang II ϭ angiotensin II AS-ODN ϭ antisense oligodeoxynucleotides AT 1 -R ϭ angiotensin II type 1 receptor CIH ϭ cold-induced hypertension CSF ϭ cerebrospinal fluid ICV ϭ intracerebroventricular RAS ϭ renin-angiotensin system SBP ϭ systolic blood pressure SCR-ODN ϭ scrambled oligodeoxynucleotides SHR ϭ spontaneously hypertensive rats
Effect of Central Injection of AS-ODN to AGT mRNA on SBP and Spontaneous Drinking Response
Blood Pressure A highly significant decrease in SBP was observed in the AS-ODN-treated rats. The result of injecting AS-ODN to AGT mRNA was that SBP was reduced from a hypertensive level (157Ϯ6 mm Hg) to a normotensive level (117Ϯ3 mm Hg) at 24 hours after injection in the AS-ODNtreated rats. Figure 2 shows the effect of central injection of AS-ODN on SBP in cold-treated rats. The SBP of AS-ODNtreated rats was significantly decreased to 117Ϯ3 mm Hg at 24 hours after injection (PϽ0.01) and to 139Ϯ5 mm Hg at 48 hours after injection (PϽ0.05). These pressures were significantly lower than those of the SCR-ODN-or artificial CSF-treated groups. There was no significant difference in the response to SCR-ODN injection (from 152Ϯ3 to 155Ϯ5 mm Hg at 24 hours after injection, to 150Ϯ7 mm Hg at 48 hours after injection, PϾ0.05) or to artificial CSF injection (from 163Ϯ5 to 155Ϯ4 mm Hg at 24 hours after injection, to 161Ϯ6 mm Hg at 48 hours after injection, PϾ0.05). Thus, AS-ODN significantly reduced SBP compared with SCR-ODN or artificial CSF administration at the same time intervals.
Drinking Response
The spontaneous drinking response was also significantly decreased by AS-ODN. Chronic cold exposure increases spontaneous drinking response (the percent increase from control is 10% at 1 week, 19% at 3 weeks, and 41% at 5 weeks during cold exposure), probably due to the increased activity of brain RAS. 8, 22 Figure 3 shows the effect of central injection of AS-ODN on spontaneous drinking response in cold-treated rats. The drinking response of AS-ODN-treated rats was significantly decreased from 49Ϯ3 to 27Ϯ4 mL/d at 24 hours after injection (PϽ0.01) and to 30Ϯ6 mL/d at 48 hours after injection (PϽ0.01). There was no significant difference in the response to SCR-ODN injection (from 59Ϯ14 to 65Ϯ6 mL/d at 24 hours after injection, to 68Ϯ6 mL/d at 48 hours after injection, PϾ0.05) or to artificial CSF injection (from 47Ϯ10 to 50Ϯ8 mL/d at 24 hours after injection, to 61Ϯ8 mL/d at 48 hours after injection, PϾ0.05). The AS-ODN significantly reduced spontaneous drinking compared with SCR-ODN or artificial CSF administration at the same time intervals (PϽ0.05).
Effect of Central Injection of AS-ODN to AT 1 -R mRNA on SBP and Drinking Response
The result of injecting AS-ODN to AT 1 -R mRNA was that SBP and water intake were reduced in the AS-ODN-treated rats. Figure 4 shows the effect of central injection of AS-ODN on SBP in cold-treated rats. The decrease in SBP began 24 hours Figure 2 ). Spontaneous drinking response of the antisense-treated rats was significantly decreased at 24 hours (**PϽ0.01) and at 48 hours (**PϽ0.01) after injection compared with SCR-ODN or artificial CSF administration at the same time intervals (nϭ6).
Blood Pressure
(from 172Ϯ6 to 138Ϯ5 mm Hg, PϽ0.05) after the single dose of 50 g (25 g/L). The SBP remained decreased by Ͼ30 mm Hg, and the maximum effect was seen 72 hours after the injection (to 131Ϯ5 mm Hg, PϽ0.01). The SBP gradually increased and reached the control level by day 5 to 6 after injection. The controls, artificial CSF and SCR-ODN, produced no significant reduction in SBP. Figure 5 shows the effect of central injection of AS-ODN on water intake in cold-treated rats. Cold increases spontaneous water intake. The drinking after AS-ODN administration was significantly decreased from 58Ϯ4 to 41Ϯ5 mL/d at 24 hours after injection (PϽ0.05). This inhibitory effect on drinking behavior was also present at 48 hours after injection (41Ϯ4 mL/d, PϽ0.05). There was no difference in water intake after SCR-ODN (from 60Ϯ4 to 51Ϯ4 mL/d at 24 hours after injection, to 47Ϯ4 mL/d at 48 hours after injection, PϾ0.05) or artificial CSF (from 58Ϯ6 to 50Ϯ6 mL/d at 24 hours after injection, to 61Ϯ6 mL/d at 48 hours after injection, PϾ0.05). The AS-ODN significantly reduced drinking compared with SCR-ODN or artificial CSF administration at the same time intervals (PϽ0.05).
Drinking Response
Effect of Peripheral Injection of AS-ODN to AT 1 -R mRNA on SBP and AT 1 -R Binding
To test the effectiveness of antisense inhibition delivered systemically, injections of AS-ODN to AT 1 -R mRNA were given. The effect of this AS-ODN inhibition was a significant reduction in SBP. A single injection with the receptor AS-ODN (100 g in 100 L saline) resulted in a significant fall in SBP of 35Ϯ5 mm Hg (PϽ0.01) in cold-treated rats ( Figure 6 ) 24 hours later. Injection with SCR-ODN showed no significant decrease in SBP (3Ϯ8 mm Hg, PϾ0.05). To examine the tissues for changes in AT 1 -R binding at 24 hours after injection, no further time points were measured. Figure 4 ). Spontaneous drinking response of the antisensetreated rats was significantly decreased at 24 hours after injection (*PϽ0.05). This effect on inhibiting drinking behavior was also present at 48 hours after injection (*PϽ0.05) compared with SCR-ODN or artificial CSF administration at the same time intervals (nϭ6). Figure 6 . Effect of peripheral injection of AT 1 -R mRNA AS-ODN on SBP in cold-treated rats. Rats were administered 100 g AS-ODN or SCR-ODN intracardially. SBP of the antisense-treated rats was significantly decreased to a normotensive level 24 hours after injection compared with SCR-ODN administration at the same time (**PϽ0.01) (nϭ6).
Figure 7.
125 I-Sar 1 ,Ile 8 -Ang II autoradiography analysis of multiple transverse sections of aorta, adrenal glands, and kidneys of cold-treated rats that received intracardiac injection in Figure 6 . Columns indicate AT 1 -R binding; error bars represent standard error. *PϽ0.05.
Autoradiography of Peripheral Tissues
Autoradiography showed that treatment with AS-ODN resulted in a significant decrease in AT 1 -R binding in aorta, adrenal glands, and kidneys when compared with the SCR-ODN treatment. These results are summarized in Figure 7 and Figure 8A through 8F. The decreases observed with 100 g AS-ODN injection were 92% in aorta, 42% in adrenal glands, and 28% in kidneys. No decrease in AT 2 -R binding was observed (data not shown). A, Aorta section of rats given SCR-ODN; B, aorta section of rats given AS-ODN to AT 1 -R mRNA; C, adrenal gland section of rats given SCR-ODN; D, adrenal gland section of rats given AS-ODN to AT 1 -R mRNA; E, kidney section of rats given SCR-ODN; and F, kidney section of rats given AS-ODN to AT 1 -R mRNA.
Discussion
Rats exposed to cold for several weeks develop a significant BP elevation. This takes 3 to 4 weeks of chronic exposure to cold. [1] [2] [3] [4] The mechanism(s) for induction of hypertension after chronic exposure to cold is incompletely understood and is presently under study. However, recent studies have implicated both the central RAS and peripheral RAS as a contributors. The peripheral RAS includes both the classic bloodborne RAS and the tissue RAS. There is an increase in mRNA for AGT and AT 1 -R in brain and peripheral tissues 7 and increased spontaneous drinking response in cold-exposed rats that respond to Ang II administration with an increased dipsogenic response. 8 The results of the present study support a role for the central and peripheral tissue RAS in the maintenance of CIH in that these experiments illustrate the viability of antisense inhibition in vivo for reduction of BP in a nongenetic, environmentally induced model of hypertension. Both antisense to AT 1 -R and AGT mRNA were successful in reducing BP centrally and antisense to AT 1 -R mRNA in reducing BP peripherally. Reduction in BP was correlated to an inhibition of spontaneous drinking response and to a reduction of AT 1 -R binding in peripheral tissues, respectively.
The results provide evidence that the brain RAS is involved in CIH. The AS-ODN to AT 1 -R mRNA inhibited the physiological effects, pressor and drinking responses, produced by central administration of Ang II. The results of this study are in keeping with the hypothesis that inhibition of mRNA translation for Ang II or AT 1 -R in the brain can reduce BP of rats with CIH. When coupled with our previous results showing that mRNA for the Ang II, AT 1 -R, spontaneous-drinking, and dipsogenic responses to administration of Ang II is increased in cold-treated rats, a role for the central RAS in this type of experimentally induced hypertension is indicated.
The data presented here confirm the effectiveness of antisense inhibition in reducing hypertension. In previous studies, we have used the same AS-ODN designs to lower BP in a genetic model of hypertension, the SHR. Gyurko et al 14 showed that central injection of AS-ODN decreased BP in SHR by blocking the protein synthesis of central AT 1 -R. Wielbo et al 17 showed that AS-ODN targeted to AGT mRNA reduced hypertension in SHR when given centrally or systemically. Morishita et al 23 also found similar AS-ODN to AGT mRNA to be effective in transient reduction of BP in SHR. The prolonged reduction in high BP in the present experiment confirms the pattern of effect of AS-ODN to AT 1 -R ICV observed in SHR. 18 The present results expand on these studies by demonstrating the effectiveness of antisense inhibition in a different model of hypertension. The CIH model is nonsurgical and nongenetic; it is an environmentally induced model of hypertension. Thus, antisense administration lowers BP in genetic-and cold-induced hypertension. The results also confirm the findings of Meng et al 24 and Sakai et al 25 that the drinking response to Ang II (ICV) can be inhibited by AS-ODN to AT 1 -R mRNA. The data suggest that the mechanism of hypertension development on exposure to cold is via increased production of AGT in the brain and consequently Ang II. Furthermore, the mechanism of CIH involves upregulated AT 1 -R. Increased Ang II synthesis and increased AT 1 -R induce the elevation of BP in cold-exposed rats and maintains it, once elevated.
Injections of AS-ODN into the heart produced a significant decrease in BP compared with injections of SCR-ODN. We used the intracardiac route for rapid dispersal of antisense in arterial blood. The results indicate that peripheral AT 1 -R contributes to the hypertension in parallel with changes in brain RAS. Control injections of SCR-ODN had no effect in central or peripheral injections. Thus, the results demonstrated that systemic administration of AS-ODN is also a viable route and is effective for antihypertensive action.
To show that the mechanism of action responsible for these physiological effects is due to sequence-specific antisense inhibition, the amount of the targeted gene product, the AT 1 -R, should be decreased. The results of the autoradiography experiments confirm a significant decrease in the number of AT 1 -R in aorta, adrenal glands, and kidneys. Whether these are the sites of action for the effect on BP or other sites are involved cannot be resolved by this analysis. The results are not due to nonspecific effects. We have used every type of control in prior experiments, including scrambled, sense, vehicle, mismatch, inverted, and even antisense to ANP to produce the opposite effects of antisense to Ang II. In every case, the antisense to AT 1 -R or to AGT mRNA produces a unique, specific response resulting in both physiological and molecular changes, indicating antisense inhibition. Earlier work by others using long oligos (22 mer or longer) with multiple repeats of G bases led to nonspecific binding. 15, 26 Sequences of 4 G cause self-annealing and misleading results. 26 Our oligo design avoids these pitfalls by using shorter ODN (15 mer) and by excluding sequences with 4 or more G repeats.
In summary, we have shown that AS-ODN, targeted to the RAS, significantly reduced BP in a rat model of hypertension that is not genetically, surgically, or pharmacologically induced. The antisense administration centrally reduces BP for 3 to 4 days after a single injection in CIH rats, and peripheral administration was effective 24 hours after a single injection. These results demonstrate that both the central and peripheral RAS are involved in CIH.
